Can-Fite BioPharma (CANF) Tops Q1 EPS by 63c, Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- S&P 500, Nasdaq set for higher open as SK Hynix lifts chips; Fed in focus
- SK Hynix shares surge after Q3 profit beats expectations
- Oil up 1% as Saudi Arabian refinery attack reignites supply concerns
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
| CAN-FITE BIOPHARMA LTD. (NYSE: CANF) | Delayed: 1.63 -0.02 (1.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.65 | 52 Week High | $3.89 | |||
| Open | $1.63 | 52 Week Low | $1.85 | |||
| Day High | $1.64 | P/E | N/A | |||
| Day Low | $1.61 | EPS | $0.00 | |||
| Volume | 14,257 | |||||
